548 related articles for article (PubMed ID: 25614426)
1. Device-detected atrial fibrillation: what to do with asymptomatic patients?
Chen-Scarabelli C; Scarabelli TM; Ellenbogen KA; Halperin JL
J Am Coll Cardiol; 2015 Jan; 65(3):281-94. PubMed ID: 25614426
[TBL] [Abstract][Full Text] [Related]
2. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
[TBL] [Abstract][Full Text] [Related]
3. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Marinkovic JM; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
[TBL] [Abstract][Full Text] [Related]
4. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
[TBL] [Abstract][Full Text] [Related]
5. Does atrial fibrillation detected by cardiac implantable electronic devices have clinical relevance?
Glotzer TV; Ziegler PD
Cardiol Clin; 2014 May; 32(2):271-81. PubMed ID: 24793802
[TBL] [Abstract][Full Text] [Related]
6. Silent atrial fibrillation as a stroke risk factor and anticoagulation indication.
Glotzer TV; Ziegler PD
Can J Cardiol; 2013 Jul; 29(7 Suppl):S14-23. PubMed ID: 23790594
[TBL] [Abstract][Full Text] [Related]
7. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
[TBL] [Abstract][Full Text] [Related]
8. Atrial high rate episodes in patients with dual-chamber cardiac implantable electronic devices: unmasking silent atrial fibrillation.
Benezet-Mazuecos J; Rubio JM; Farré J
Pacing Clin Electrophysiol; 2014 Aug; 37(8):1080-6. PubMed ID: 24888216
[TBL] [Abstract][Full Text] [Related]
9. [Atrial fibrillation and stroke].
Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D
Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293
[TBL] [Abstract][Full Text] [Related]
10. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
[TBL] [Abstract][Full Text] [Related]
11. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding.
Mascarenhas DA; Farooq MU; Ziegler PD; Kantharia BK
Europace; 2016 Jun; 18(6):799-806. PubMed ID: 26614520
[TBL] [Abstract][Full Text] [Related]
12. Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation.
Miyazawa K; Pastori D; Lip GYH
Prog Cardiovasc Dis; 2018; 60(4-5):537-541. PubMed ID: 29289494
[TBL] [Abstract][Full Text] [Related]
13. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
14. Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke.
Al-Gibbawi M; Ayinde HO; Bhatia NK; El-Chami MF; Westerman SB; Leon AR; Shah AD; Patel AM; De Lurgio DB; Tompkins CM; Lloyd MS; Merchant FM; Kiani S
Heart Rhythm; 2021 Mar; 18(3):338-346. PubMed ID: 33250442
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future.
AlTurki A; Marafi M; Russo V; Proietti R; Essebag V
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547078
[TBL] [Abstract][Full Text] [Related]
16. The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).
Ertas F; Eren NK; Kaya H; Aribas A; Acar G; Kanadasi M; Gedik S; Oylumlu M; Yuksel M; Ulgen MS;
Cardiol J; 2013; 20(4):447-52. PubMed ID: 23677730
[TBL] [Abstract][Full Text] [Related]
17. Direct thrombin and factor Xa inhibition for stroke prevention in patients with atrial fibrillation.
Galanis T; Merli GJ
Hosp Pract (1995); 2013 Feb; 41(1):26-36. PubMed ID: 23466965
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.
Boriani G; Pettorelli D
Vascul Pharmacol; 2016 Aug; 83():26-35. PubMed ID: 27196706
[TBL] [Abstract][Full Text] [Related]
19. Early detection of occult atrial fibrillation and stroke prevention.
Keach JW; Bradley SM; Turakhia MP; Maddox TM
Heart; 2015 Jul; 101(14):1097-102. PubMed ID: 25935765
[TBL] [Abstract][Full Text] [Related]
20. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
